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The S14 (spot 14) gene encodes a protein that is predominantly ex-
pressed in lipogenic tissues, such as the liver, white and brown
adipose tissues and the lactating mammary glands. Accumulated
evidence suggests that S14 could play an important role in the
induction of lipogenic enzymes. In humans, the S14 locus resides
in the chromosome region 11q13, which is frequently amplified in
breast tumours, and as a result, it has been suggested that this
protein could play a role in the metabolism and growth of these
kinds of tumours. In the present study, we have examined the
effects of S14 overexpression in MCF-7 human breast cancer
cells. We found that S14 causes (i) an inhibition of cell prolifer-
ation and of anchorage-independent growth, (ii) a marked reduc-
tion in the number of viable cells and (iii) the induction of
differentiation and cell death of these cells. The inhibition of cell
growth was associated with a decrease in the expression of cyclin
D1 and a reduction of cyclin D1 promoter activity. Increased
expression of S14 also caused the accumulation of cytochrome
c in the cytosol and loss of mitochondrial membrane potential.
These findings suggest that S14 may function as an important
modulator of tumorigenesis in human breast by decreasing cell
growth and inducing cell death and differentiation.
Key words: apoptosis, breast cancer, lipid accumulation, MCF-7,
proliferation, spot 14.
INTRODUCTION
The S14 (spot 14) gene encodes a small acidic protein (first de-
scribed as a thyroid-hormone-regulated gene [1]) that is pre-
dominantly expressed in tissues producing lipids such as the
liver, white and brown adipose tissues and the lactating mammary
glands [2]. Very early after cloning of this sequence, the ex-
pression of S14 in lipogenic tissues, together with its regulation by
hormones and physiological manoeuvres that altered lipogenesis
in experimental animals, generated a clear correlation between the
expression of this gene and lipogenesis [3–6]. Experiments with
S14 knockout mice also implicated this protein in lipid meta-
bolism, being essential in the lactating mammary gland, although
not for the induction of lipogenesis in the liver by thyroid hormone
[7,8].
Despite its close correlation with lipogenic processes, the
specific function of the S14 protein remains unclear. Recently,
it has been suggested that S14 binds non-esterified fatty acids
and in this way could facilitate the activity of fatty acid synthase
[8]. This observation is in agreement with the initial idea of S14
being a cytosolic protein [9]. Alternatively, the observation that
the S14 protein is present in the nucleus of hepatic cells [10] has
opened up the possibility that this protein could play a role in
the expression of lipogenic enzymes. In fact, the transfection of
hepatocytes with S14 antisense oligonucleotides led to reduced
triacylglycerol formation and an attenuated expression of genes
involved in the lipogenic pathway, such as malic enzyme, ATP
citrate lyase and FAS (fatty acid synthase) [11].
In human breast carcinoma cells, the expression of lipogenic
enzymes is frequently increased and associated with a poor pro-
gnosis [12,13]. FAS is implicated in tumorigenesis through its role
in membrane lipid synthesis and cell proliferation and has been
shown to be induced in breast carcinoma cells by HER 2 activ-
ation and progestins [14,15]. Inhibition of FAS activity is cyto-
toxic in breast tumour cells and induces programmed cell death
[16,17]. On the other hand, it is well known that induction of dif-
ferentiation is one potent mechanism by which some cancer thera-
peutic and chemopreventive agents work [18]. One of the markers
of functional differentiation of mammary tissue is the induc-
tion of lipid droplets. These lipid droplets are composed mainly of
triacylglycerols and constitute an important component of milk.
An accumulation of lipid droplets has been observed in many
breast cancer cell lines after treatment with diverse agents that also
induce growth arrest, including retinoic acid, vitamin D3, 15dPG-
J2 (15-deoxy--12,14-prostaglandin J2) and antibiotics [19–24].
The human S14 gene is located on the long arm of chromosome
11 (11q13.5), a region implicated in human obesity [25,26]. It is
also known that this region is amplified in several aggressive breast
cancers, and this amplification predicts a poor prognosis [27,28].
In addition, it has been suggested that S14 could play a role in
breast cancer cell lipogenesis, where its expression is induced
by progestins in parallel with lipogenic enzymes [29,30]. Hence,
an implication of S14 protein in breast tumour development has
been proposed [25]. However, such a role in breast cancer is yet
to be proven directly. In the present study, we found that stable
overexpression of S14 inhibits the growth of MCF-7 breast cancer
cells. We further demonstrate that S14 is able to inhibit anchorage-
independent growth in soft agar and induce apoptosis of these
cells. Lastly, we have found that known differentiating agents
of breast cancer cells, such as retinoic acid, vitamin D3 and
15dPG-J2 induced the endogenous expression of the human S14
gene in MCF-7 cells.
Abbreviations used: BrdUrd, bromodeoxyuridine; CMV, cytomegalovirus; 15dPG-J2, 15-deoxy--12,14-prostaglandin J2; FAS, fatty acid synthase; FBS,
fetal bovine serum; MS14, S14-transfected MCF-7 cells; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide; S14, spot 14; TMRE,
tetramethylrhodamine methyl ester perchlorate.
1 Correspondence may be addressed to either of these authors (email aperez@iib.uam.es or piedras3@med.ucm.es).
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EXPERIMENTAL
Cell culture and transfection
MCF-7 cells were propagated and maintained in RPMI 1640
medium (Life Technologies, Basel, Switzerland) containing 10%
(v/v) FBS (fetal bovine serum) at 5% CO2 and 37 ◦C in saturated
humidity. For the selection of S14 stably transfected cells, MCF-
7 cells were plated at a density of 1 × 105 cells/60 mm dish and
transfected 24 h later with CMVS14 expression vector driven
by the CMV (cytomegalovirus) promoter using Transfast (In-
nogenetics, Madison, WI, U.S.A.), according to the manu-
facturer’s instructions. The CMVS14 expression vector was con-
structed by cloning a 461 bp EcoRI cDNA fragment containing the
entire coding region of the human S14 gene into the mammalian
expression vector pCDNA3. Empty vector was also transfected
into cells to serve as a control. After 12 h of transfection, the
medium was replaced and the cells were incubated for 24 h, after
which they were subcultured at 1:15 dilution with the addition
of geneticin (1 mg/ml). The growth medium was renewed every
3 days, and fresh geneticin was added until colonies appeared.
Individual clones were then isolated and expanded to confirm
the expression of S14 by Western-blot and immunofluorescence
analyses. Parental cells and cells transfected with the empty
vector were analysed as controls. No significant differences were
observed between either cell line and, therefore, only the data
obtained with MB (vector-transfected MCF-7 cells) are shown.
Experimental cultures were usually grown in 10% resin–charcoal
stripped FBS for the indicated times.
For transient transfection experiments, MCF-7 cells were
seeded on to 12-well plates, grown in regular medium (RPMI 1640
medium containing 10% FBS) for 24 h, and transfected with a
construct containing 1720 bp of the human promoter of the cyclin
D1 gene [31] cloned in the pXP2luc vector. MCF-7 cells were
transfected with this construct, and with the CMVβgal vector
for transfection efficiency, using LipofectamineTM (Promega,
Madison, WI, U.S.A.) according to the manufacturer’s instruc-
tions. Typically, cells received 2 µg of luciferase reporter plasmid
and were harvested 24 h after growing in experimental media for
the determination of luciferase and β-galactosidase (for deter-
mination of transfection efficiency) activities.
Antibodies
The E132 polyclonal antibody specific for S14 was obtained
by injecting rabbits with a peptide corresponding to the amino
acids 49–146 fused to the glutathione S-transferase protein.
Mouse monoclonal antibody directed to cytochrome c and rabbit
polyclonal anti-cyclin D1 were obtained from Pharmingen (San
Diego, CA, U.S.A.) and Santa Cruz Biotechnology (Heidelberg,
Germany) respectively. The E132 antibody was tested for
specificity by preincubating it for 45 min with the peptide used
to immunize the rabbits. The preincubation completely inhibited
S14 staining by the E132 antibody.
Western-blot analysis
Equal amounts of the total cellular protein were separated by
SDS/PAGE (12% polyacrylamide). After electrophoresis, pro-
teins were transferred on to BioTrace PVDF membranes
(GelmanSciences, Ann Arbor, MI, U.S.A.). Blots were blocked
with 5% (w/v) dry milk (anti-cyclin D1) or 3% (w/v) BSA
(anti-cytochrome c and E132) in PBS containing 0.5% (v/v)
Tween 20 for 60 min and probed with the appropriate antibodies
for 12 h at 4 ◦C. After washing, membranes were incubated with
peroxidase-conjugated secondary antibodies and specific proteins
were detected with the ECL® (enhanced chemiluminescence)
system (Amersham Biosciences, Piscataway, NJ, U.S.A.).
Confocal microscopy
Cells were plated on glass coverslips in 24-well cell-culture plates
and grown in regular medium for 24 h before switching to a
medium containing 10% (v/v) stripped serum for the specified
times. The cells were then washed and fixed for 10 min with
methanol at −20 ◦C. After a 1 h incubation at room temperature
(22 ◦C) with the primary antibody, cells were washed with PBS
and incubated with an Alexa 488-labelled (Molecular Probes,
Leiden, The Netherlands) secondary antibody for 45 min at 37 ◦C.
Subcellular localization was determined using a TCS SP2 laser
scanning spectral confocal microscope (Leica Mycrosystems,
Mannheim, Germany). The images were obtained using a series
of 0.5 µm (depth) spaced cell fluorescent slices (Z-axis).
Proliferation assay
To monitor proliferation, cells were seeded, in triplicate, on to
96-well plates at a density of 7000 cells/well. After 24 h of
growth in regular medium the cells were switched to a medium
containing 10% stripped serum and incubated for a further 24 h.
Radiolabelled [3H]thymidine (0.5 µCi) was then added and the
cells were grown for an additional 8 h. [3H]Thymidine incorpor-
ation was assessed in a Wallac 1450 MicroBeta liquid-scintil-
lation counter. Proliferation was also measured by BrdUrd
(bromodeoxyuridine) staining. Cells were seeded on glass cover-
slips in 24-well cell-culture plates and grown for 24 h in 10%
stripped serum. During the last 6 or 20 h of culture, 25 µg/ml
BrdUrd (Sigma) was added. BrdUrd-labelled cells were identified
with an anti-BrdUrd monoclonal antibody (Sigma).
Cell viability
Cell viability was measured using the MTT [3-(4,5-di-
methylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide] assay
(Roche Diagnostic, Basel, Switzerland), based on the ability of
viable cells to reduce yellow MTT to blue formazan. Briefly, cells
were cultured in 96-well microtitre plates for various periods
of time, then cells were incubated with MTT (0.5 mg/ml; 4 h)
and subsequently solubilized in 5% DMSO/5 mM HCl for at
least 2 h in the dark. The extent of reduction of MTT was
quantified by measuring the absorbance at 550 nm according to
the manufacturer’s instructions. Cell viability was also assessed by
propidium iodide (1 µg/ml) staining followed by FACS analysis.
Clonogenic survival determination
For the evaluation of colony-forming ability, cells were seeded in
specified number in 60 mm dishes in regular medium. After 24 h
of culture, the medium was replaced by the experimental medium
and cells were grown for 14 days and then stained with 0.5%
Crystal Violet in methanol.
Soft agar colony assays
Anchorage-independent growth was determined by first suspend-
ing 10000 cells in 0.35% agar in a tissue culture medium con-
taining 10% stripped serum in 60 mm plates over a bottom layer
of 0.5% agar in the medium. The cells were allowed to grow
at 37 ◦C with refeeding twice a week. After 3 weeks, the dishes
were examined by microscopy for the appearance of colonies,
after staining with Crystal Violet.
Nile Red staining
Nile Red staining was performed essentially as described in [32].
Briefly, cells were seeded in a six-well plate, grown for 72 h in a
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medium containing 10% stripped serum, washed with TD buffer
(20 mM Tris/HCl, pH 7.4, 1 mMNa2HPO4, 140 mM NaCl and
5 mM KCl), and directly stained with 1 ml of 0.1 µg/ml final
concentration of the fluorescent stain Nile Red (Sigma) in TD for
5 min. Sample observation was carried out immediately after its
preparation. Nile Red-stained cells were then examined with a
Zeiss Axiophot microscope.
Determination of apoptotic cells
To calculate the extent of cell death, cells were grown in regular
medium for 24 h and then switched to a medium containing
10% stripped serum for 6 h, and phosphatidylserine exposure
on the surface of apoptotic cells was detected by flow cytometry
after staining with annexin V-FITC (Bender MedSystems, Vienna,
Austria). Flow cytometry analysis was performed on an FACScan
cytometer using the Cell Quest software (Becton Dickinson,
Cowley, Oxford, U.K.).
Analysis of the mitochondrial transmembrane potential (m)
Variations in the m in vivo during apoptosis were studied using
TMRE (tetramethylrhodamine methyl ester perchlorate; Mol-
ecular Probes). TMRE is a cationic, membrane-permeant dye
that accumulates in the negatively charged mitochondrial matrix
in response to m. MCF-7 cells were grown for 24 h in a
medium containing 10% stripped serum; afterwards, they were
incubated for 30–45 min at 37 ◦C in the presence of 50 nM TMRE,
as indicated, followed by analysis in an FACScan flow cytometer.
Measurement of cytochrome c release
For the analysis of cytochrome c release, cells were grown for 48 h
in serum-stripped medium, trypsinized, washed with TD buffer
and resuspended in 30 µl of lysis buffer (PBS containing 80 mM
KCl, 250 mM sucrose, 1 mM dithiothreitol, protease inhibitors
and 500 µg/ml digitonin). Cells were incubated in the lysis
buffer for 8 min at 4 ◦C and collected after centrifugation at
10000 g for 5 min. The supernatant was respun for a further 5 min
at 10000 g. After washing, the first pellet was resuspended in
PBS and sonicated to obtain the mitochondrial fraction. Both the
second supernatant, representing the cytosol including the light-
membrane fraction, and the mitochondrial fraction were loaded
on to a 12% polyacrylamide gel, and cytochrome c release was
analysed by immunoblotting. In order to visualize cytochrome
c in cells that had been labelled with 20 nM Mitotracker Red
CMXRos (Molecular Probes), MCF-7 cells were grown on glass
coverslips and immunofluorescence analysis was performed as
described above.
Statistical analysis
The data shown are the means +− S.D. for at least three independent
experiments. Statistical comparisons for significance between
cells with different treatments were performed using Student’s
t test. ANOVA was used to analyse the data of Figure 6(B).
RESULTS
Effect of S14 overexpression on MCF-7 cell growth
and differentiation
To assess directly the possible effects of the S14 protein on mam-
mary tumour cells, we generated stably transfected human MCF-7
breast cancer cell lines. The complete human S14 cDNA, cloned
into a CMV-driven expression vector, was transfected into MCF-
7 cells, and different geneticin-resistant clones were tested for
S14 expression using the E132 polyclonal antibody. MCF-7 cells
Figure 1 Stable overexpression of S14 in MCF-7 human breast cancer cells
(A) Western-blot analysis of S14 was performed with 20 µg of total cellular proteins extracted
from MB and MS14 cells. S14 protein was detected by incubation with the E132 polyclonal
antibody as described in the Experimental section. A representative Western blot is shown.
(B) Immunofluorescence analysis of S14 subcellular localization. Confocal images were taken
at a × 20 and × 63 magnification.
stably transfected with the pCDNA3 vector alone were used as
controls. For the rest of the experiments, we chose to use clones
MB and MS14 (S14-transfected MCF-7 cells). As can be seen in
Figure 1(A), clone MS14 showed very high levels of S14 protein
when compared with MB cells. The differences in the amount of
S14 protein between clones MB and MS14 could also be observed
by immunofluorescence analysis (Figure 1B). In clone MB, a
weak and diffuse signal could be observed throughout the cell
body in contrast with a much stronger signal detected in clone
MS14, which is localized mainly in the cytoplasm, albeit there
was also some signal in the nucleus.
We first examined the effects of S14 overexpression on MCF-7
cell growth by monitoring cell proliferation in a [3H]thymidine
incorporation assay. Growing MS14 cells in experimental
medium for 8 h resulted in a 60 +− 5% inhibition of thymidine
incorporation, when compared with control MB cells (Figure 2A).
This growth inhibitory effect was further confirmed by BrdUrd
incorporation (Figure 2B). In line with the results obtained using
[3H]thymidine incorporation, a decrease of approx. 50 +− 11% in
the number of positive cells was detected after 20 h of growing
in experimental medium. Next, we performed colony-forming
assays and, as shown in Figure 2(C), overexpression of S14
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Figure 2 Effects of S14 overexpression on the growth properties of MCF-7
cells
(A) MB and MS14 cells were grown as described in the Experimental section and the
incorporation of [3H]thymidine was determined. Results are the means for three determinations
from three different experiments. ***P < 0.001. (B) MB and MS14 cells were grown as described
in the Experimental section and immunostained with an anti-BrdUrd antibody. The images were
obtained using a laser-scanning confocal microscope. (C) Representative colony-forming assay
in MB and MS14 cells. Experiments were repeated three times on duplicate samples.
significantly diminished colony formation relative to vector-
transfected control cells. Thus S14 appears to function as a growth
suppressive factor of breast cancer cells.
Cyclin D1 is overexpressed in more than 30% of human breast
cancers and mammary gland-targeted expression of cyclin D1
is sufficient for the induction of mammary tumorigenesis [33].
Hence, we next performed Western-blot analysis to determine
whether overexpression of S14 alters the cellular levels of cyclin
D1. We found that MS14 cells displayed a marked reduction in the
cyclin D1 protein (Figure 3A). To examine whether the decreased
Figure 3 Effect of S14 on cyclin D1 expression
(A) Western-blot analysis of cyclin D1 was performed with 20 µg of total cellular proteins
extracted from MB and MS14 cells. Cyclin D1 protein was detected by incubation with an
anti-cyclin D1 polyclonal antibody as described in the Experimental section. A representative
Western blot is shown. (B) Transient transfection of a cyclin D1 promoter construct was performed
as indicated in the Experimental section. Results shown are the average of at least three different
experiments performed in triplicate. ***P < 0.001.
Figure 4 Anchorage-independent growth of MB and MS14 cells in soft agar
Representative microphotographs (×4 magnification) of clones are shown.
levels of cyclin D1 in S14-overexpressing cells might be due to an
inhibition of the transcription of the cyclin D1 gene, we examined
the effects of S14 on the transcriptional activity of the cyclin D1
promoter in transient transfection experiments using a cyclin
D1 reporter containing 1720 bp of the human cyclin D1 promoter
region. After transfection of this reporter into MB or MS14 cells,
we observed a significant decrease in the activity of the cyclin
D1 promoter in cells overexpressing S14 when compared with
control MB cells (Figure 3B).
The ability of cancer cells to grow without adhering to
extracellular matrix proteins (anchorage-independent growth)
correlates closely with their ability to form malignant tumours.
Anchorage-independent growth presumably allows the cells to
invade and metastasize, characteristics that distinguish malignant
from benign tumours. Thus, to assess the effect of S14 over-
expression on anchorage-independent growth of MCF-7 cells,
we seeded MB and MS14 cells in a medium containing 0.35%
agar and counted the colonies 21 days later. As shown in Fig-
ure 4, we observed a significant reduction in the number and
size of the colonies of S14-expressing MCF-7 cells compared
with vector-transfected cells (37 +− 7 and 27 +− 3 colonies/mm2
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Figure 5 Nile Red staining of lipid droplets
Fluorescence microphotographs taken at ×40 (left panels) and ×100 (right panels) fold
magnification of MB and MS14 cells stained with Nile Red
respectively; P 0.01). Hence, S14 expression partially inhibited
the anchorage-independent growth of MCF-7 cells.
We then examined the formation of lipid droplets as a indicator
of breast cancer cell differentiation. As shown in Figure 5, control
MB cells expressed only minimal detectable lipid vacuoles. In
contrast, most of the MS14 cells underwent a morphological
change where they became filled with neutral lipid that stained
with Nile Red, suggesting that S14 overexpression promoted
MCF-7 cell differentiation.
Effect of S14 overexpression on MCF-7 cell death
Having demonstrated that S14 overexpression in MCF-7 cells
resulted in a reduction in cell growth and an induction of
differentiation, we next asked whether overexpressing S14 could
also cause cell death in MCF-7 cells. A significant increase in the
number of dead cells measured by propidium iodide staining and
subsequent flow cytometry analysis was detected in the MS14
cell line 24 h after growing the cells in experimental medium
(Figure 6A). By using the MTT assay, we further confirmed
the loss of cell viability of MS14 cells in comparison with MB
cells (Figure 6B). Analysis of an early marker of apoptosis,
annexin V staining, indicated that 2.2% of the MS14 cell popu-
lation was induced to undergo apoptosis in comparison with the
1.0% found in control MB cells (Figure 7A). To confirm that
S14 overexpression induces apoptosis in MCF-7 cells, Hoechst
staining was also performed, and typical morphological features
of apoptotic nuclei, such as DNA condensation and nuclear
shrinkage, were observed in MS14 cells (Figure 7B).
There is increasing evidence that a decrease in the m is
associated with mitochondrial dysfunction, and an altered mito-
chondrial function is linked to apoptosis and loss of cell viability.
Hence, we next examined the effect of S14 overexpression on the
m of MCF-7 cells. We measured m using the fluorescent
probe TMRE and monitored using flow cytometry. As shown in
Figure 8(A), the mitochondrial fluorescence decays and is very
low in the MS14 line, compared with the MB clone, after 24 h of
growth in serum-stripped medium.
Mitochondrial factors, including cytochrome c, are released
following the induction of apoptosis. Immunoblot analysis of
cytosolic extracts prepared from control MB and MS14 cells
demonstrated an increase in the presence of cytosolic cytochrome
Figure 6 Effects of S14 overexpression on the cell viability of MCF-7 cells
MB and MS14 cells were incubated in serum-stripped medium for the indicated time periods,
and cell viability was determined by propidium iodide staining, *P < 0.05 (A), or by the MTT
assay, P  0.01 (B) as indicated in the Experimental section.
Figure 7 Effect of S14 overexpression on apoptosis of MCF-7 cells
(A) MB and MS14 cells were grown in serum-stripped medium for 6 h; afterwards, the number
of apoptotic cells was determined by annexin V-FITC staining and FACS analysis. Results of
three independent experiments are shown. * P < 0.05. (B) Hoechst staining showing chromatin
condensation in MS14 cells.
c in cells overexpressing the S14 protein (Figure 8B). To further
confirm these results, we performed confocal microscopy studies
using specific anti-cytochrome c antibodies. As can be seen in
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Figure 8 Effects of S14 overexpression on m and cytochrome c release in MCF-7 cells
(A) MB and MS14 cells were cultured in serum-stripped medium for 24 h; 30 min before harvesting, cells were treated with 50 nM TMRE and analysed by flow cytometry. Results shown are the
average fluorescence intensities in percentage. *P < 0.05. (B) Representative Western-blot analysis of cytochrome c release. Cytoplasmic and mitochondrial extracts were obtained as described
in the Experimental section. (C) Subcellular distribution of cytochrome c. MB and MS14 cells were grown on glass coverslips, as indicated in the Experimental section, and incubated with 20 nM
MitoTracker Red CMXRos for 45 min. After fixing, immunofluorescence analysis was performed with a specific anti-cytochrome c antibody (green) and fluorescence was visualized by confocal
microscopy. Representative results of three independent experiments are shown.
Figure 8(C), the anti-cytochrome c antibody revealed a diffuse
extramitochondrial localization of cytochrome c in the majority
of the MS14 cells, whereas in all MB cells, cytochrome c had
a punctuate distribution and co-localized with the mitochondrial
marker Mitotracker Red CMXRos.
Induction of S14 expression by several antitumorigenic agents
Many different studies have shown that activation of different
members of the nuclear receptor superfamily, including retinoic
acid receptor, vitamin D3 receptor and peroxisome proliferator-
activated receptors is involved in the regulation of cell growth, dif-
ferentiation and apoptosis of breast cancer cells. We next evalu-
ated the effects of well-characterized ligands of these receptors,
all-trans retinoic acid, vitamin D3 and 15dPG-J2, on the endo-
genous expression of S14 in parental MCF-7 and SKBr-3
(another human mammary cancer epithelial cell line) cells that
have not been transfected with pCDNA3 or pCDNAS14. S14 ex-
pression markedly increased in MCF-7 cells 24 h after treatment
with 100 µM all-trans retinoic acid, 100 µM vitamin D3 and
10 µM 15dPG-J2 (Figure 9). Interestingly, after treatment with
retinoic acid or vitamin D3, the S14 protein is localized in both
the nucleus and the cytosol; however, when the stimulus was
15dPG-J2, the S14 signal was detected primarily in the nucleus.
In SKBr-3 cells, S14 protein levels were clearly induced after
treatment with 15dPG-J2; however, no significant increase could
be observed when the cells were grown in the presence of either
retinoic acid or vitamin D3.
Effect of S14 overexpression on the MS14′ clone
To dismiss the possibility that the anti-growth properties exhibited
by the MS14 cells could be secondary to a cytotoxic effect due
to the high levels of S14 protein present in this clone, we next
studied another clone (MS14′) having a lower level of expression
of this protein (Figure 10A). The MS14′ clone also inhibited
[3H]thymidine incorporation, increased the apoptotic population,
and reduced anchorage-independent growth (Figures 10B–10D)
in a manner similar to that of MS14 cells.
Effect of S14 overexpression on T47D cells
Finally, we examined whether the effect of S14 overexpression
was similar in other breast cancer cells. To this end, we generated
stably transfected human T47D cells overexpressing S14 (TS14)
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Figure 9 Regulation of endogenous S14 protein levels in MCF-7 and SKBr-3 cells
Cells were grown on glass coverslips in serum-free medium and treated or not for 24 h with all-trans retinoic acid (1 µM), vitamin D3 (1 µM) or 15dPG-J2 (10 µM). After fixing, immunofluorescence
analysis was performed with the E132 polyclonal antibody and fluorescence was visualized by confocal microscopy.
and vector-transfected cells (TB), used as controls. Consistent
with its effect on MCF-7 cells, overexpression of S14 caused
a significant decrease in proliferation and growth in soft agar
(Figures 11A and 11B), and induced the number of cells with
chromatin condensation and the accumulation of lipid droplets
(Figures 11C and 11D).
DISCUSSION
The results presented in this paper provide novel information
on the role of S14 protein in the control of human breast cancer
cell growth. In this study, we showed that induced expression of
S14 inhibited in vitro growth of MCF-7 cancer cells, which was
associated with the down-regulation of cyclin D1 protein levels
and expression. In addition, S14 induced differentiation and cell
death of MCF-7 cells.
Lipid metabolism seems to be an important factor to be con-
sidered when the outcome of human breast cancer is evaluated.
High levels of expression of FAS in human breast cancer are
related to a poor prognosis and inhibitors of this enzyme caused
breast cancer cell death in vitro [12,13,16,17]. On the other hand,
it is well known that, in breast cancer, many anti-tumour drugs
act through induction of the differentiation and accumulation of
lipid droplets [34].
A previous work has shown that the mRNA for S14 is expressed
in several breast cancer cell lines, including MDA-MB-134,
MDA-MB-453, T47D and MCF-7 [25]. Since the expression of
this protein is related to lipogenesis in normal tissues [2,6,7,11]
and because S14 appears to regulate the expression of lipogenic
enzymes, such as FAS, acetyl-CoA carboxylase and ATP citrate
lyase, in tissues like the liver [11], it has been suggested that
an increase in the expression of this protein could provide an
explanation for the increased lipid synthesis in breast tumour
cells and, therefore, play a role in tumour cell development [25].
Nevertheless, the precise role of S14 in breast cancer tumori-
genesis is still unknown. The results presented here clearly
demonstrate that MCF-7 stable cell lines that constitutively
overexpressed S14 proliferated much more slowly than control
stable cell lines. This antiproliferative effect does not seem to
represent a non-specific cytotoxic action of S14 due to the high
levels of this protein in MS14 cells, since similar expression levels
are observed after retinoic acid or 15dPG-J2 treatment of parental
MCF-7 cells (Figure 9). This inhibition of growth was associated
with a decrease in the levels of the G1 cell-cycle control protein,
cyclin D1. Furthermore, our results with the cyclin D1 promoter
suggest that S14 could inhibit the transcriptional activity of the
human cyclin D1 promoter, although we cannot discard an indirect
effect due to the reduced proliferation rates in MS14 cells. Thus
S14 appears to decrease the levels of cyclin D1 protein by inhibit-
ing de novo transcription of cyclin D1. Deregulated cyclin
D1 expression triggers autonomous growth under serum-free
conditions and overrides antimitogenic signals in tumour cells,
strongly implicating cyclin D1 in tumorigenesis [35,36]. In line
with these observations, the cyclin D1 gene is also frequently
amplified and overexpressed in breast tumours [37]. All these
results suggest that inhibition of cyclin D1 expression may be
relevant for the antiproliferative action of S14 in MCF-7 cells.
Sweeney et al. [38] have recently shown that epidermal growth
factor and neuregulin 1, two very potent inducers of proliferation
and survival of human breast cancer cells, reduce the expression
of S14 in MDA-MB-361 cells. Using microarray analysis, these
authors have shown that activation of the ErbB family of receptor
tyrosine kinases with different ligands lead to the regulation of a
number of genes that play a role in the survival, growth, pro-
gression or invasiveness of breast cancer cells. Transcripts
encoding cyclins D1 and D3, E2F transcription factor, jun B
protooncogen or egr1 (early growth response protein 1) were
stimulated in response to the growth factors. On the other hand,
putative tumour suppressor genes, such as the transcription factor
AP2, the homeobox protein Cdx2, amphiphysin II and CGM2
were suppressed by growth factor stimulation, along with the S14
gene. These results further support the notion that S14 could act
as a negative regulator of human breast cancer cell growth.
S14 overexpression also induced differentiation of MCF-7
cells, as measured by the accumulation of lipid droplets. These
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Figure 10 Growth properties of the MS14′ clone
(A) Western-blot analysis of S14 was performed with 20 µg of total cellular proteins extracted
from MCF-7, MB, MS14 and MS14′ cells. S14 protein was detected by incubation with the E132
polyclonal antibody as described in the Experimental section. A representative Western blot is
shown. Incorporation of [3H]thymidine (B), analysis of apoptosis (C) and anchorage-independent
growth (D) were determined, as described in the Experimental section. *P < 0.05; **P < 0.01;
***P < 0.001.
results are in concurrence with numerous data from the literature
showing that many antitumour drugs act through the induction
of differentiation and accumulation of lipid droplets [24,34].
Besides, we also show that ligands of three nuclear receptors,
which have been previously shown to promote terminal differ-
entiation and inhibition of growth of breast tumour cells,
considerably increase the expression of the human endogenous
S14 gene to levels similar to those observed in MS14 cells.
Nuclear hormone receptors, which comprise among others the
receptors for steroids and thyroid hormones, retinoids, vitamin D3
and peroxisome proliferators, are members of a large family of
ligand-inducible transcription factors that regulates a plethora
of (patho)physiological processes (reviewed in [39]). Regarding
their actions on breast cancer cells, nuclear receptors comprise
two principal categories: those that stimulate growth and those
Figure 11 Effect of S14 overexpression on the human mammary epithelial
cell line T47D (TS14)
T47D cells were grown under the same conditions as MCF-7 cells and incorporation of
3H-thymidine (A), analysis of anchorage-independent growth (B), Hoechst staining (C) and
Nile Red staining (D) were determined, as described in the Experimental section. TB, vector-
transfected cells.
that interfere negatively with cell proliferation. Oestrogen and
androgen receptors are predominantly growth-stimulatory recep-
tors. In contrast, ligands of retinoic acid receptors, vitamin D re-
ceptor and peroxisome proliferator-activated receptors have pro-
nounced antiproliferative potential, which is usually linked to the
capacity to induce differentiation and/or cell death (reviewed in
[40]). A large body of evidence indicates that all-trans retinoic
acid, vitamin D3 and 15dPG-J2 exhibit significant antiproliferative
and differentiation-promoting activities towards several malig-
nant cell types, including breast cancer [41–43]. Then, our results
raise the possibility that the S14 gene could play a role as a
mediator of the actions of these factors on breast cancer cells.
In conclusion, these observations suggest that S14 may be
involved in the regulation of breast cancer cell growth and devel-
opment, and this gene could represent a molecular target for
chemoprevention of breast cancer.
c© 2005 Biochemical Society
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